$13.6 Million is the total value of AGTC Partners, L.P.'s 2 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | Acceleron Pharma Inc. | $13,220,000 | -21.3% | 530,919 | 0.0% | 97.39% | +7.2% | |
| BGMD | Sell | BG Medicine, Inc. | $354,000 | -79.0% | 863,269 | -71.8% | 2.61% | -71.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc. | 4 | Q3 2015 | 97.4% |
| BG Medicine, Inc. | 4 | Q3 2015 | 10.9% |
View AGTC Partners, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2015-11-13 |
| 4 | 2015-07-29 |
| 4 | 2015-07-29 |
| 13F-HR | 2015-07-28 |
| 4 | 2015-07-16 |
| 13F-HR | 2015-04-30 |
| 13F-HR | 2015-02-12 |
| 3 | 2013-09-18 |
| 4 | 2013-02-01 |
| 4 | 2011-02-11 |
View AGTC Partners, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.